{"article_title": "Healthcare Sector's Malaise Creates Buying Opportunity for ETF Investors", "article_keywords": ["sector", "investors", "sectors", "xlv", "traded", "told", "creates", "etfs", "malaise", "etf", "healthcare", "uninsured", "health", "care", "opportunity", "buying", "smead"], "article_url": "https://www.etftrends.com/2016/03/healthcare-sector-malaise-creates-buying-opportunity-for-etf-investors/", "article_text": "After being one of the best performers among the sector SPDR exchange traded funds over the past two years and for much of the current bull market, the Health Care Select Sector SPDR (NYSEArca: XLV) is down more than 6% year-to-date.\n\nWhile XLV and its rivals rank among the worst-performing sector ETFs this year, the healthcare sector\u2019s malaise could be creating a buying opportunity in the group, particularly for investors looking for a sector to buy and hold for the long-term.\n\nFor XLV and rival healthcare ETFs, the good news is that the U.S. economy moving into the late-cycle phase, overall growth may slow and signs of an economic slowdown could pop up. Consequently, investors may also turn to defensive sectors that are less economically sensitive, such as health care. [Sector ETFs for the Late Business Cycle]\n\nThe Affordable Care Act has helped millions of Americans receive healthcare coverage, with the uninsured rate now at a seven-year low, bolstering the outlook for healthcare services and sector-related exchange traded funds. The uninsured rate has declined almost 6 percentage points since late 2013, before the ACA, or Obamacare, took effect. More Americans gaining access to health insurance could bolster the long-term thesis for the iShares U.S. Healthcare Providers ETF (NYSEArca: IHF).\n\nSmead Capital Management Bill Smead told CNBC Monday he likes \u201cMerck, Pfizer, and Amgen, companies that he said boast price-to-earnings ratios well below broader market measures, \u2018fantastic\u2019 dividends, and free cash flow.\u201d\n\nIn an election, political rhetoric looms large for healthcare stocks and ETFs like XLV, but Smead addressed that situation as well.\n\nThe sector will drop \u201cto the point at which no one wants to own them, rather than six months later when you\u2019re closer to the end of the populist rhetoric,\u201d Smead told CNBC.\n\nHealth Care Select Sector SPDR\n\nThe opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.", "article_metadata": {"description": "The healthcare sector's malaise could be creating a buying opportunity in the group, particularly for investors looking for a sector to buy and hold for the", "generator": "WordPress 4.5.2", "msapplication-TileImage": "https://www.etftrends.com/wp-content/uploads/2016/04/favicon-1.png", "keywords": "healthcare etfs,sector etfs,xlv,equities,featured", "google-site-verification": "Q-wAoS5rW2yMYxQN_OT0klqLjkfU6a6rxznKurdUlsY", "viewport": "width=device-width, initial-scale=1"}, "article_summary": "Consequently, investors may also turn to defensive sectors that are less economically sensitive, such as health care.\nWhile XLV and its rivals rank among the worst-performing sector ETFs this year, the healthcare sector\u2019s malaise could be creating a buying opportunity in the group, particularly for investors looking for a sector to buy and hold for the long-term.\nHealth Care Select Sector SPDRThe opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass.\nMore Americans gaining access to health insurance could bolster the long-term thesis for the iShares U.S. Healthcare Providers ETF (NYSEArca: IHF).\nFor XLV and rival healthcare ETFs, the good news is that the U.S. economy moving into the late-cycle phase, overall growth may slow and signs of an economic slowdown could pop up."}